1.
Senna M, Taylor S, Piraccini BM, Shapiro J, Somani N, Jedynak JP, Ogwu S, Buchanan A, Craiglow B, Ohyama M. Characterizing Loss of Response Occurring in a Small Number of Patients During 3 Years of Long-Term Maintenance Therapy with Baricitinib 4-mg: Results From BRAVE-AA1 and -AA2 Trials. J of Skin [Internet]. 2025Jan.13 [cited 2025Mar.13];9(1):s522. Available from: https://skin.dermsquared.com/skin/article/view/3165